RCT: Tenecteplase vs. alteplase for the management of acute ischemic stroke.
20 May, 2022 | 10:43h | UTCTenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial – The Lancet Neurology (link to abstract – $ for full-text)